AAPL 179.06 +0.32 (+0.18%)MSFT 126.11 +0.03 (+0.02%)FB 181.06 +0.03 (+0.02%)ZNGA 6.06 -0.02 (-0.33%)NVDA 144.95 -0.07 (-0.05%)WBA 51.77 +0.01 (+0.02%)GOOG 1133.33 +0.71 (+0.06%)PIH 5.61 -0.09 (-1.58%)
AAPL 179.06 +0.32 (+0.18%)MSFT 126.11 +0.03 (+0.02%)FB 181.06 +0.03 (+0.02%)ZNGA 6.06 -0.02 (-0.33%)NVDA 144.95 -0.07 (-0.05%)WBA 51.77 +0.01 (+0.02%)GOOG 1133.33 +0.71 (+0.06%)PIH 5.61 -0.09 (-1.58%)

Financial Summary IFRX Quote InflaRx N.V

InflaRx N.V. Quote

InflaRx N.V. (IFRX)

35.30 0.16 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
D+
Symbol IFRX
Price 35.30
Beta -0.67
Vol Avg 66.13 K
Mkt cap 1.02 B
Shares 23
Last Div Not Available
Div Yield 0.00%
DCF Unlevered 0.00
DCF Levered 0.00
ROE 55.56% Strong Buy
ROA -250.00% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt/Equity -116.67% Sell
P/E -162.38 Strong Sell
P/B -45.11 Strong Sell
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 0 0 0 0 0
COGS 0 0 0 0 0
GrossProfit 0 0 0 0 0
Depreciation (included in COGS) 0 0 0 0 0
StockBasedCompe (included in COGS) 0 0 0 1 5
ResearchAndDeve 0 0 3 5 14
SalesGeneralAnd 0 0 0 2 5
OperatingIncome 0 0 -4 -7 -20
InterestExpense 0 0 1 2 2
OtherIncome 0 0 0 0 -2
IncomeBeforeTax 0 0 -5 -9 -24
ProvisionForInc 0 0 0 0 0
NetIncome 0 0 -5 -9 -24
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 0 0 3 29 123
ShortTermInvest 0 0 0 0 0
Cash 0 0 3 0 0
AccountReceivab 0 0 0 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 0 0 0 0
TotalCurrentAss 0 0 3 29 124
PPE 0 0 0 0 0
AccumulatedDepr 0 0 0 0 0
NetPPE 0 0 0 0 0
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 0 0 0 0 0
TotalNonCurrent 0 0 0 0 0
TotalAssets 0 0 4 30 124
ShortTermDebt 0 0 0 0 0
AccountsPayable 0 0 0 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 0 0 0 0 0
TotalCurrentLia 0 0 0 2 5
Debt 0 0 0 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 0 0 21 53 0
TotalNonCurrent 0 0 21 53 0
TotalLiabilitie 0 0 21 55 5
CommonStock 0 0 0 0 3
AdditionalPaidI 0 0 0 0 0
RetainedEarning 0 0 -18 -27 -51
AccumulatedOthe 0 0 0 0 0
TotalStockholde 0 0 -18 -26 119
TotalLiabilitie 0 0 4 30 124
Cash Flow Statement
Year 20142015201620172018
NetIncome 0 0 -5 -9 -24
Depreciation 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 0 0 0 1 5
AccountsReceiva 0 0 0 0 0
InventoryCS 0 0 0 0 0
AccountsPayable 0 0 0 0 3
OtherWorkingCap 0 0 0 1 0
OtherNonCashIte 0 0 1 2 5
NetCashProvided 0 0 -3 -5 -12
InvestmentsInPP 0 0 0 0 0
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve 0 0 0 0 0
SalesMaturities 0 0 0 0 0
PurchasesOfInta 0 0 0 0 0
OtherInvestingA 0 0 0 0 0
NetCashUsedForI 0 0 0 0 0
DebtIssued 0 0 0 0 0
DebtRepayment 0 0 0 0 0
CommonStockIssu 0 0 0 0 91
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 0 0 0 0 -9
NetCashProvided 0 0 0 31 109
NetChangeInCash 0 0 -3 26 94
CashAtBeginning 0 0 7 3 29
CashAtEndOfPeri 0 0 3 29 123
Retained Earnings
Year 20142015201620172018
RetainedEarning -----
NetIncome -----5
StockDividend ----23
DividendPaid -----
RetainedEarning -----18
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE -----
DeprAnnual 0----
CapitalExpendit 00000
NetPPE -----
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0----
Amortization 0----
NewPurchases 0----
intAndGW -----
Company Profile

CEO

Niels Riedemann

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.